This is an opportunity to own a profitable retail cannabis store with an excellent brand and reputation in the cannabis marketplace.

This store offers recreational and medical marijuana options to retail consumers. The positive cash flow operation is appropriate for an entrepreneur seeking either the option to be hands-on, or hands-off as an absentee owner. This store has a strong leadership team that will remain in place after the sale. Having a strong team will enable the new owner to be as hands-on as they choose while benefiting financially from the current staff's experience. Executive management has designed and deployed strong systems, infrastructure, staff, and tenant-improvements. This stable situation allows the new owner a turnkey business that has already addressed all variables in this industry. The store is operated by experienced in house retail shop managers ready to grow. The business offers not only a revenue generating retail location but also offers a new buyer to the retail cannabis industry the opportunity to build on the established footprint and or an existing owner to reach the five retail license limit currently in place in Washington.

New legislation makes 2026 the perfect time to enter the cannabis industry, especially with an established client base and strong brand reputation. On December 18, 2025, President Donald Trump signed Executive Order 14370 directing the US Attorney General to reschedule marijuana from a Schedule 1 drug to a Schedule 3 drug. The result of this change once fully implemented will eliminate the application of 280E for cannabis licensed businesses when filing their federal income taxes. With this change, cannabis business owners will be able to deduct all administrative expenses. Up to now, cannabis owners could only deduct the cost of goods sold from their taxable revenues. The impact is estimated to be a 30-35% increase in annual cash flow. Additional benefits from the removal of 280E will be the potential increase in investors as well as potential price reductions to cannabis product sales as owners weigh the balance of retaining income after taxes and sharing the tax savings for customer satisfaction and market share growth.

This retail cannabis store provides a full range of cannabis products from flower, concentrates, cartridges, edibles, pre- rolled joints, vaporizers, topicals to medical marijuana. The shop features the most popular budget, value, and luxury brands in every commodity group offered in a comfortable contemporary retail setting. For example, some of the brands include Rays Lemonade, Northwest Concentrates, Bondi Farms Pre-rolls, Wyldes Edibles, Fairwinds Topicals and more.
In addition to strong product lines, the business has a reputation for providing superb customer service.

When customers visit their cannabis location, they are greeted by friendly staff and experience a unique concierge-level customer service offering superior product knowledge tailored to the needs of a cannabis user. In addition to the shop being exceptionally merchandised for product presentation and selection, all budtenders provide this special 1:1 customer experience, unlike any other in the area. This exceptionally trained staff will continue on with the new owner to maintain this bespoke level of customer service and retain customers.

The current owner has set up the future buyer for success with seamless processes, effective marketing, and fully compliant operations under the regulation of the Washington’s Liquor and Cannabis Board.

The US cannabis industry generated approximately $30 Billion in sales in 2025 and is expected to
increase to approximately $47 billion by the end of this year (2026); Roughly 47% of citizens in cannabis legal states use cannabis; and 64% of users are now using cannabis for relaxation purposes. The US cannabis market is expected to grow annually between 11-15% on a compounded annual growth rate (CAGR) into 2030.